Post on 20-Dec-2015
TUBERCOLOSISAgis Terzidis, Paediatrician Spyridon Gialamas, Medical Doctor
SEMINAR ON TROPICAL AND TRAVEL MEDICINE AT TTCIH
IFAKARA 25 JUNE 2009
Estimated TB incidence rates, by country, 2007
Source: WHO
Trends in estimated incidence rates in nine subregions, 1990-2007
Source: WHO
Progress towards the 70% case-detection target
Source: WHO
Tuberculosis supranational reference laboratory network, 2007
Source: WHO
Countries that had reported at least one case of extensively drug-resistant TB
Source: WHO
Global Fund commitments for TB control by region, as of end 2008
Western Pacific Region20% (US$ 755 million)
African Region29% (US$ 1131 million)
Southeast Asia Region22% (US$ 867 million)
European Region13% (US$ 502 million)
Region of the Americas6% (US$ 229 million)
Eastern Mediterranean Region10% (US$ 382 million)
Source: WHO
Objectives for 2006–2015 of the WorkingGroup on New TB Diagnostics:
• address existing gaps in knowledge that are obstructing development of new diagnostic tools
• develop and evaluate a portfolio of new diagnostic tools and demonstrate their impact
• implement new diagnostic tools and ensure access to them
Source: WHO
Strategic plan for 2006–2015 of the WorkingGroup on New TB Drugs:
• Identification and validation of new targets for drugs, and candidate compounds
• drug development• planning and execution of more effective clinical trials,
including identification of improved biomarkers and methods of assessing latent disease
• clear and efficient regulatory guidance
Source: WHO
Strategic plan for 2006–2015 of the WorkingGroup on TB Vaccines:
• maintain and improve BCG vaccination programmes. The next generation of new vaccines introduced as an addition to BCG vaccines
• expand discovery and translation research on vaccines (“keeping the pipeline filled”)
• facilitate preclinical development of new vaccines• build capacity at vaccine trial sites, providing opportunities
for training and capacity strengthening
AHSANTENI